Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
The psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy contro...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Human Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/full |
id |
doaj-50830f81d4e34f1b8dd2e7a958f5e5b7 |
---|---|
record_format |
Article |
spelling |
doaj-50830f81d4e34f1b8dd2e7a958f5e5b72020-12-08T08:40:13ZengFrontiers Media S.A.Frontiers in Human Neuroscience1662-51612020-11-011410.3389/fnhum.2020.571035571035Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse HeadacheSimone Migliore0Matteo Paolucci1Livia Quintiliani2Claudia Altamura3Sabrina Maffi4Giulia D’Aurizio5Giuseppe Curcio6Fabrizio Vernieri7Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyPsychology Service, University Campus Bio-Medico, Rome, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyHuntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyThe psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy controls (HC). Headache frequency, drug consumption, HIT-6, and MIDAS scores were recorded. All participants filled in the following questionnaires: Beck Depression Inventory-II Edition (BDI-2), trait subtest of State-Trait Anxiety Inventory (STAI-Y), Difficulties in Emotion Regulation Scale (DERS), Barratt Impulsiveness Scale (BIS-11), Toronto Alexithymia Scale (TAS-20). The primary endpoint was to establish if MOH patients have an altered psychopathological profile. The secondary endpoint was to establish whether the worst profile correlates with the worsening of headache and disability measures. We enrolled 48 consecutive MOH patients and 48 HC. MOH patients showed greater difficulty in recognition/regulation of emotions (DERS, TAS-20), depression (BDI-2), anxiety (STAI-Y), and impulsiveness (BIS-11). We found a positive correlation among DERS, BDI-2, STAI-Y, and BIS scores and MIDAS and HIT-6 scores and among DERS and headache frequency and drug consumption. MOH patients showed a high rate of emotion regulation difficulties, depression, and anxiety, which may negatively affect their headaches. The ability to regulate/recognize emotions may play a central role in sustaining medication overuse.https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/fullemotion regulationemotion recognition (ER)psychopatological profilemedication overuse headache (MOH)behavioral approach |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Simone Migliore Matteo Paolucci Livia Quintiliani Claudia Altamura Sabrina Maffi Giulia D’Aurizio Giuseppe Curcio Fabrizio Vernieri |
spellingShingle |
Simone Migliore Matteo Paolucci Livia Quintiliani Claudia Altamura Sabrina Maffi Giulia D’Aurizio Giuseppe Curcio Fabrizio Vernieri Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache Frontiers in Human Neuroscience emotion regulation emotion recognition (ER) psychopatological profile medication overuse headache (MOH) behavioral approach |
author_facet |
Simone Migliore Matteo Paolucci Livia Quintiliani Claudia Altamura Sabrina Maffi Giulia D’Aurizio Giuseppe Curcio Fabrizio Vernieri |
author_sort |
Simone Migliore |
title |
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache |
title_short |
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache |
title_full |
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache |
title_fullStr |
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache |
title_full_unstemmed |
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache |
title_sort |
psychopathological comorbidities and clinical variables in patients with medication overuse headache |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Human Neuroscience |
issn |
1662-5161 |
publishDate |
2020-11-01 |
description |
The psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy controls (HC). Headache frequency, drug consumption, HIT-6, and MIDAS scores were recorded. All participants filled in the following questionnaires: Beck Depression Inventory-II Edition (BDI-2), trait subtest of State-Trait Anxiety Inventory (STAI-Y), Difficulties in Emotion Regulation Scale (DERS), Barratt Impulsiveness Scale (BIS-11), Toronto Alexithymia Scale (TAS-20). The primary endpoint was to establish if MOH patients have an altered psychopathological profile. The secondary endpoint was to establish whether the worst profile correlates with the worsening of headache and disability measures. We enrolled 48 consecutive MOH patients and 48 HC. MOH patients showed greater difficulty in recognition/regulation of emotions (DERS, TAS-20), depression (BDI-2), anxiety (STAI-Y), and impulsiveness (BIS-11). We found a positive correlation among DERS, BDI-2, STAI-Y, and BIS scores and MIDAS and HIT-6 scores and among DERS and headache frequency and drug consumption. MOH patients showed a high rate of emotion regulation difficulties, depression, and anxiety, which may negatively affect their headaches. The ability to regulate/recognize emotions may play a central role in sustaining medication overuse. |
topic |
emotion regulation emotion recognition (ER) psychopatological profile medication overuse headache (MOH) behavioral approach |
url |
https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/full |
work_keys_str_mv |
AT simonemigliore psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT matteopaolucci psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT liviaquintiliani psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT claudiaaltamura psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT sabrinamaffi psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT giuliadaurizio psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT giuseppecurcio psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache AT fabriziovernieri psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache |
_version_ |
1724390398745378816 |